VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

704 hedge funds and large institutions have $40.2B invested in Vertex Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 93 funds opening new positions, 233 increasing their positions, 264 reducing their positions, and 78 closing their positions.

Holders
704
Holders Change
+9
Holders Change %
+1.29%
% of All Funds
15.71%
Holding in Top 10
16
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.36%
New
93
Increased
233
Reduced
264
Closed
78
Calls
$403M
Puts
$412M
Net Calls
-$9.15M
Net Calls Change
-$59.9M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.39B
2
AllianceBernstein
2
AllianceBernstein
Tennessee
$486M
3
Capital World Investors
3
Capital World Investors
California
$1.64B
4
Jennison Associates
4
Jennison Associates
New York
$1.15B
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$4.27B

Top Sellers

1
Ameriprise
1
Ameriprise
Minnesota
$721M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$1.43B
3
JIM
3
Jupiter Investment Management
United Kingdom
$123M
4
Capital Research Global Investors
4
Capital Research Global Investors
California
$342M
5
Prudential Financial
5
Prudential Financial
New Jersey
$54.4M
Name Market Value Shares Shares
Change 		Shares
Change %
Allianz Asset Management
26
Allianz Asset Management
Germany
$286M 1,726,147 -35,845 -2%
Bank of America
27
Bank of America
North Carolina
$269M 1,626,134 -206,511 -11%
PI
28
Putnam Investments
Massachusetts
$243M 1,464,323 -142,737 -9%
BB
29
BB Biotech
Switzerland
$227M 1,370,445 – –
UBS AM
30
UBS AM
Illinois
$225M 1,359,479 +36,635 +3%
PAM
31
Panagora Asset Management
Massachusetts
$221M 1,335,889 -118,675 -8%
Millennium Management
32
Millennium Management
New York
$204M 1,230,851 +222,524 +22%
Franklin Resources
33
Franklin Resources
California
$201M 1,213,494 -22,441 -2%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$194M 1,168,601 -96,755 -8%
Legal & General Group
35
Legal & General Group
United Kingdom
$191M 1,153,579 +79,216 +7%
O
36
OrbiMed
New York
$188M 1,133,200 -467,300 -29%
VOYA Investment Management
37
VOYA Investment Management
Georgia
$185M 1,116,778 -286,756 -20%
Sumitomo Mitsui Trust Group
38
Sumitomo Mitsui Trust Group
Japan
$173M 1,071,949 +164,403 +18%
TCIM
39
TIAA CREF Investment Management
New York
$165M 993,287 -440,752 -31%
Charles Schwab
40
Charles Schwab
California
$162M 978,907 +46,494 +5%
Deutsche Bank
41
Deutsche Bank
Germany
$160M 964,009 -332,854 -26%
American Century Companies
42
American Century Companies
Missouri
$159M 959,557 -188,868 -16%
EVM
43
Eaton Vance Management
Massachusetts
$150M 906,823 +5,871 +0.7%
Citadel Advisors
44
Citadel Advisors
Florida
$146M 883,523 +54,690 +7%
Janus Henderson Group
45
Janus Henderson Group
United Kingdom
$146M 880,574 +366,207 +71%
Swiss National Bank
46
Swiss National Bank
Switzerland
$138M 830,909 +17,400 +2%
Arrowstreet Capital
47
Arrowstreet Capital
Massachusetts
$131M 792,173 -9,694 -1%
AQR Capital Management
48
AQR Capital Management
Connecticut
$126M 759,033 -522,311 -41%
Morgan Stanley
49
Morgan Stanley
New York
$124M 747,140 +56,373 +8%
Two Sigma Advisers
50
Two Sigma Advisers
New York
$123M 745,012 +219,000 +42%
1
2
3 4 5